skin cancer Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions. Castle Biosciences Awarded VA Supply Contract for Melanoma Test The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military. Castle Biosciences Q2 Revenues Rise 79 Percent The company said it delivered 70 percent more DecisionDx-Melanoma test results year over year, and that the total number of all tests delivered more than doubled. Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic The company's DecisionDx-SCC is meant to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors. Castle Biosciences to Expand Range of Dermatology Diagnostics Beyond Cancer Premium The company said it is developing a new genomic test to predict therapeutic response in patients with inflammatory skin conditions. May 10, 2021 Castle Biosciences Q1 Revenues Up 31 Percent Mar 11, 2021 Eye Color GWAS Leads to 50 New Loci, Underscoring Trait's Complexity Mar 8, 2021 Castle Biosciences Q4 Revenues Down 2 Percent Mar 5, 2021 DermTech Q4 Revenues Up 31 Percent Feb 16, 2021 Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases Feb 12, 2021 DermTech Enters Agreement With Blue Cross Blue Shield of Texas for Skin Cancer Assay Jan 7, 2021 DermTech Prices $125M Public Offering of Common Stock Jun 22, 2020 Genomic Study Reveals Recurrent Cutaneous Melanoma Alterations, Male-Specific Mutations Jun 5, 2020 Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type Apr 27, 2020 Cutaneous Melanoma Clues Found From Risky SNPs, Related Traits Analyses Mar 9, 2020 DermTech Trying to Drum up Payor Coverage for Melanoma Test With Study Results Premium Nov 11, 2019 Castle Biosciences Q3 2019 Revenues Quadruple Sep 24, 2019 SkylineDx Partners With Mayo Clinic on Melanoma Risk Test Study Ahead of Planned US Trial Premium Sep 16, 2019 Australian Skin Cancer Genetic Study Seeks to Recruit 20K Additional Participants Sep 3, 2019 Castle Biosciences Q2 Revenues Up 168 Percent Jul 25, 2019 Castle Bio Prices IPO at $16 per Share Mar 7, 2019 Mutagenic Processes in Cancer Cell Lines Can Be Persistent, Episodic Oct 22, 2018 GeneATLAS Database Documents Diverse Trait Associations Detected With UK Biobank Data Oct 4, 2018 Geneseq, Australian Clinical Labs Partner to Commercialize Melanoma Test Aug 22, 2018 APOBEC-Linked Mutational Signatures Drive Skin Cancer in Recessive Dystrophic Epidermolysis Bullosa Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.